DexCom, Inc. (NASDAQ:DXCM)

CAPS Rating: 1 out of 5

A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.

Recs

1
Player Avatar plaws213 (96.02) Submitted: 6/16/2009 10:03:31 AM : Outperform Start Price: $6.50 DXCM Score: +425.22

Who wants to prick their finger six times a day?

Featured Broker Partners


Advertisement